VIDEX EC

Product NDC: 0087-6673
11-digit product format: 000876673
Labeler code: 0087
Product ID: 0087-6673_ef8e48eb-df78-465d-9748-b3c1c8e1e2d3
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: didanosine
Dosage form: CAPSULE, DELAYED RELEASE
Route: ORAL
Labeler: Bristol-Myers Squibb Company
Application: NDA021183
Marketing category: NDA
Marketing start: 2000-10-31
Marketing end: 2021-10-31
Substance: DIDANOSINE
Active strength: 250 mg/1
Pharmacologic classes: Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleoside Analog [EXT],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC exclude flag: No
Listing certified through: 0000-00-00
Current FDA listing: Historical FDA.report record

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
0087-6673-17	EA - Each	0087-6673	401a18b0-97ac-4fdd-a7d5-4d186c4789e7	1	2012-07-24

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
K3GDH6OH08	DIDANOSINE	69655-05-6	DIDANOSINE

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Marketing start	Marketing end	Sample	Exclude flag	Status
0087-6673-17	00087667317	30 CAPSULE, DELAYED RELEASE in 1 BOTTLE (0087-6673-17)	2000-10-31	2021-10-31	No	No	Current